Natriuretic peptide-guided treatment for heart failure: a systematic review and meta-analysis
<p>Background: GUIDE-IT, the largest trial to date, published in August 2017, evaluating the effectiveness of natriuretic peptide-guided treatment of heart failure, was stopped early for futility on a composite outcome. However, the reported effect sizes on individual outcomes of all-cause m...
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ
2019
|